These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2638124)

  • 1. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol.
    Herink J; Koupilová M; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on cholinergic enhancement therapy for Alzheimer disease.
    Read SL
    Bull Clin Neurosci; 1987; 52():34-7. PubMed ID: 3334548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B; Stoof JC
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract]   [Full Text] [Related]  

  • 4. First experience with the application of 7-methoxytacrine to psychiatric patients.
    Zapletálek M; Hanus H; Fusek J; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):305-6. PubMed ID: 2576923
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of tacrine derivatives on the behaviour of laboratory rats.
    Koupilová M; Herink J; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):301-3. PubMed ID: 2638123
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic trials using tacrine and other cholinesterase inhibitors.
    Gamzu ER; Thal LJ; Davis KL
    Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo.
    Bajgar J; Patocka J; Fusek J; Hrdina V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(4):425-35. PubMed ID: 6599819
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrine in Alzheimer's disease.
    Levy R
    Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
    Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against soman-induced seizures in rats: relationship among doses of prophylactics, soman, and adjuncts.
    Myhrer T; Nguyen NH; Andersen JM; Aas P
    Toxicol Appl Pharmacol; 2004 May; 196(3):327-36. PubMed ID: 15094303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotective therapy of Alzheimer's disease?].
    Mielke R
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1515. PubMed ID: 8983909
    [No Abstract]   [Full Text] [Related]  

  • 14. Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.
    Hallak M; Giacobini E
    Neuropharmacology; 1989 Mar; 28(3):199-206. PubMed ID: 2725846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of triazolam in convulsions induced by pentylenetetrazol.
    Herink J; Koupilová M; Bajgar J
    Homeost Health Dis; 1991; 33(4):181. PubMed ID: 1818697
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydroaminoacridine and lecithin for Alzheimer's disease.
    N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type.
    N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrahydroaminoacridine and Alzheimer's disease.
    Lancet; 1987 Feb; 1(8530):444-5. PubMed ID: 2880235
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetrahydroaminoacridine and Alzheimer's disease.
    Levy R
    Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydroaminoacridine in Alzheimer's disease.
    Walsh AC
    BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.